Psychedelic Drugs as Therapeutics: No Illusions About the Challenges

Interest in the potential therapeutic benefits of psychedelic agents has recently increased. In addition to psilocybin, a wide variety of agents with psychedelic properties have been proposed and partially tested. However, the challenges of obtaining approval to market a restricted psychotomimetic a...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2018-04, Vol.103 (4), p.561-564
Main Authors: Sellers, Edward M., Leiderman, Deborah B.
Format: Article
Language:English
Subjects:
Drug Approval - methods
Drug Discovery - ethics
Drug Discovery - methods
Hallucinogens - pharmacology
Hallucinogens - therapeutic use
Humans
Mental Disorders - drug therapy
Patient Selection
Risk Evaluation and Mitigation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Interest in the potential therapeutic benefits of psychedelic agents has recently increased. In addition to psilocybin, a wide variety of agents with psychedelic properties have been proposed and partially tested. However, the challenges of obtaining approval to market a restricted psychotomimetic agent are formidable.
ISSN:0009-9236
1532-6535
DOI:10.1002/cpt.776